BDBM620953 (4S)-3-{2-[(3-tert-butyl-1,2- thiazol-5-yl)amino]quinazolin-7- yl}-4-methyl-1,3-oxazolidin-2- one::US20230303540, Example Ex-8.10

SMILES C[C@H]1COC(=O)N1c1ccc2cnc(Nc3cc(ns3)C(C)(C)C)nc2c1

InChI Key InChIKey=KPPNDPYWXARXDN-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 620953   

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM620953(US20230303540, Example Ex-8.10 | (4S)-3-{2-[(3-ter...)
Affinity DataIC50: 0.625nMAssay Description:The LRRK2 kinase activity reported herein as IC50 values was determined with LanthaScreen technology from Life Technologies Corporation (Carlsbad, CA...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
US Patent